How much does The Vaccine App make per month?

Based on our ML-calibrated revenue forecast, The Vaccine App earns approximately $101/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.

Is The Vaccine App profitable?

With estimated build cost $155K and monthly revenue $101, The Vaccine App looks well below break-even — current monthly revenue is much smaller than the estimated build cost. Profitability also depends on paid-acquisition spend and refund rate which the public model doesn't see.

What apps are like The Vaccine App?

Browse the full Medical category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.

What is The Vaccine App built with?

Our heuristic places The Vaccine App on the Native Android (Kotlin) stack (High confidence, 80%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: Flutter.

Is The Vaccine App still actively maintained?

Maintenance status: Likely abandoned (95% abandonment risk). Last shipped version was 2+ years ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.

When was The Vaccine App last updated?

The Vaccine App last shipped a new version on 2023-11-08 — more than 2 year(s) ago. This is the date Apple / Google last accepted a new build, not a content-only push.

Who makes The Vaccine App?

The Vaccine App is published by Medsafe Holdings Ltd on the Google Play Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.

What is The Vaccine App's BU Score?

The Vaccine App has a BU Score of 35/100 (Emerging). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.

The Vaccine App

Quality Score

Emerging

The Vaccine App

Name: The Vaccine App — app revenue, audience, build cost & risk profile
Creator: Bumetric
License: https://creativecommons.org/licenses/by/4.0/
Keywords: The Vaccine App revenue, The Vaccine App app analytics, mobile app revenue estimate, Medical revenue, Android app revenue

by Medsafe Holdings Ltd

Low confidence

2.6 Google Play rating

✍️ Bumetric analysis

“

The Vaccine App is an Android app from Medsafe Holdings Ltd in the Medical category, currently rated 2.6★ across 52 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.

Quality Score is 35: Emerging (early traction worth watching). For a Medical app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.

Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.

💰 Monthly revenue · now vs forecast

● Right now

$101

per month

→

12-mo forecast

$51 – $472

per month

→

24-mo forecast

$51 – $1414

per month

MICRO tier

💡 Grow this revenue

Free AI audit of this app’s store listing

Title & subtitle keyword fit
Description hook & conversion structure
Screenshots, ratings, reviews strategy

Run free AI audit →

Typical impact: +2-5× organic installs

📊 Performance Tracking LIVE

1 snapshots on record

idle

Rating

2.6

Reviews

52 reviews

Forecast Revenue / mo

$101

Snapshots tracked

since Jul 2026

ONE-TIME · BUILD 💰 Estimated build cost

$155K

↳ What it cost to build · not monthly revenue

Likely range $115K – $210K

$25K · MVP floor $100K · indie scale $500K+ · studio build

📈 Slow ROI — current MRR is well below build cost

Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.

Where the money goes

🧱 MVP baseline (design + 1-store ship)	+$28K
📱 5 unique screens × $4.5K	+$22K
⚙ Medical complexity ×1.55	+$27K
🌐 Cross-platform reach (iOS + Android)	+$43K
⚙ 6.0y maintenance × ~1-person team	+$35K

Total estimate $155K

🛠 Estimated tech stack

🤖

Native Android (Kotlin)

High confidence · 80%

Also possible

Flutter

Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.

Signals we read

🏷 Category context	Medical
📦 Compact Android bundle	→ Native Kotlin

💀 Maintenance status

Likely abandoned

95%

Last shipped 2023-11-08 · 1052 days ago

0 · Active 50 · At risk 100 · Abandoned

Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.

Risk signals

📅 2y+ since last update	Likely abandoned
👥 Small user base (52 ratings) + 6.0y old	+10% (solo-project pattern)

Verdict Likely abandoned

🔬

How we forecast this revenue

LOW CONFIDENCE

Baseline

$101/mo · ML-estimated from 234 triggers

Growth rate

+8.0% MoM · MICRO tier baseline (compound monthly)

Direction

Headwinds: rating drift may slow acquisition

6 months

$64 – $257

12 months

$51 – $472

24 months

$51 – $1.4K

Compound growth at +8.0% MoM (tier baseline for MICRO). Range widens with horizon — typical noise band ±60% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.

📊

BU Investment Matrix

Insufficient data · 27/100MICRO TIERtoo early to score

Growth Velocity

5.0

Founder Strength

3.0

Product Quality

2.1

Revenue Strength

2.0

Monetization Maturity

1.0

Defensibility

3.5

Market Position

0.0

Operational Safety

5.0

💰 Revenue: Marginal — $0 - $500/mo · MICRO tier · indicative confidence, trajectory unclear.
⭐ Quality: 2.64★ across 52 reviews — weak — significant quality concerns.
📍 Market: Not yet charting in any of the 9 monitored markets.
📈 Growth: ⚠ last update 1051d ago — possibly dormant.
⚠️ Risk: Elevated — dormant (1051d since update).

🎯 For competitors: Vulnerable. Quality drift + slow updates create a clear opening for a fresh competitor with active dev cadence.

💵 For acquirers: Estimated asking range 18-32× monthly = $1K-$3K.

Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.

Range:

💰 Forecast Revenue / mo

MODEL

Revenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.

🔬Forecast Breakdown — Why This Estimate?Top 6 of 6 triggers

Our ML model uses 200+ signals from public data. These are the most influential for this app:

bugsREVIEW		−$1,800
Below-average rating (2.6★)METRIC		−$1,500
support teamREVIEW		+$900
Established app (5y old)METRIC		+$800
Ad-supported / freemiumMETRIC		+$600
Pre-traction phase (52 ratings)METRIC		−$300

METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)

📥 Estimated Downloads / week

PROXY · ratings × 50/wk —

Industry-rule estimate (Sensor Tower / data.ai): one weekly install ≈ 50 new ratings. Solid points = tracked snapshots · faded line = pre-tracking model backfill.

📈 Reviews Growth

LIVE

Cumulative review count from first BU snapshot. Each point = a tracked update.

⭐ Rating Trend

LIVE

Average rating evolution. Updates with each new review batch.

🗓️ Snapshot Timeline

HISTORY

Each bar shows a tracked update and the metric delta from the previous snapshot.

Profile & Insights

Everything we know — and don't — about this app and its company.

Identification

App name: The Vaccine App
Developer: Medsafe Holdings Ltd
Bundle ID: com.thevaccineapp.app
App Store URL: Open in App Store
Category: Medical
Content rating: Not found
Languages: Not found

Company

Website: thevaccineapp.com
Tagline: Not found
Description: Not found
Founded: Not found
HQ / Address: Not found
Employees: Not found
Logo: Not found

Revenue

Reported revenue signal / mo: Not found
AI revenue estimate / mo: Not found
AI annual estimate: Not found
Model estimate / mo: $101/mo
Top-grossing rank: Not found
All-time revenue: Not found
Pricing: Not found

Founder

Founder data not yet collected for this app.

Funding

Funding data not yet collected for this app.

Press & Links

Press & Links data not yet collected for this app.

Contacts & Socials

Contacts & Socials data not yet collected for this app.

Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.

📝 About this app

Children need vaccines for a range of different diseases and at very specific ages and intervals. Schools and governments require proof of these vaccines on official cards which are often misplaced. The Vaccine App manages this schedule effortlessly and officially.  You will receive reminders 2 weeks before the immunisation is due and your health care provider will digitally sign the app giving you an official record you will never lose again.

A PDF option to print your official vaccine record is included.

Key Features

Track up to 3 children on the app… View full description on the official store →

App Specs

🔐 Own this app? Claim & verify MRR →

🔖 v1.2.76🔄 updated 2y ago📂 Medical💰 Free🚀 Launched 2020 (5y old)

🧪